Gaithersburg, MD, United States of America

Li Shi

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 16.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Li Shi

Introduction

Li Shi is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies for cancer treatment. With a total of 3 patents to her name, Li Shi is recognized for her innovative approaches to addressing complex medical challenges.

Latest Patents

Among her latest patents, Li Shi has developed Anti-B7-H1 antibodies for treating tumors. These patents detail methods of treating B7-H1-expressing tumors by administering an effective amount of MEDI4736 or an antigen-binding fragment thereof. This groundbreaking work has the potential to improve treatment options for patients suffering from various types of cancer.

Career Highlights

Li Shi is currently employed at MedImmune Limited, where she continues to advance her research in immunotherapy. Her work has garnered attention in the scientific community, and she is recognized for her dedication to improving patient outcomes through innovative treatments.

Collaborations

Throughout her career, Li Shi has collaborated with notable colleagues, including Rajesh Narwal and David Fairman. These partnerships have fostered a collaborative environment that enhances the development of new therapeutic strategies.

Conclusion

Li Shi's contributions to the field of biotechnology exemplify the impact of innovative thinking in medicine. Her work in developing Anti-B7-H1 antibodies showcases her commitment to advancing cancer treatment. As she continues her research at MedImmune Limited, her future endeavors are sure to make a lasting impact in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…